Axt INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
AXTI
Axt INCAXT, Inc. announced robust financial results for the second quarter of 2026, with revenue soaring to $47.6 million and net income reaching $11.1 million, driven by strong demand in data center optical connectivity.
NASDAQ
AXTI
Axt INCAXT, Inc. announced a significant long-term supplier agreement with Lumentum Operations, LLC, securing a minimum annual commitment for indium phosphide wafer substrates through 2031 and receiving substantial upfront deposits.
NASDAQ
AXTI
Axt INCAXT, Inc. has amended its bylaws to reduce the quorum requirement for shareholder meetings from a majority to thirty-three and one-third percent of voting shares.
NASDAQ
AXTI
Axt INCAXT, Inc. has appointed Jia-Bin Duh to its Board of Directors, expanding the board to six members and bringing over 30 years of executive leadership experience.
NASDAQ
AXTI
Axt INCAXT, Inc. subsidiary Tongmei has withdrawn its IPO application from China's STAR Market to pursue a listing on the Hong Kong Stock Exchange, shifting focus to its indium phosphide business.
NASDAQ
AXTI
Axt INCAXT, Inc. has entered into a significant Master Development and Supply Agreement with Coherent Corp for the mass development and supply of 6-inch indium phosphide (InP) wafer substrates.
NASDAQ
AXTI
Axt INCAXT's subsidiary, Tongmei, has entered into a significant long-term supply agreement with Nanjing Casela Technologies for indium phosphide wafer substrates.
NASDAQ
AXTI
Axt INCAXT, Inc. announced the approval of a significant increase in authorized common stock shares and the election of directors at its 2026 Annual Meeting.
NASDAQ
AXTI
Axt INCAXT, Inc. has adjourned its 2026 Annual Meeting of Stockholders to June 4, 2026, due to an insufficient number of shares present to constitute a quorum.
NASDAQ
AXTI
Axt INCAXT, Inc. announced the pricing of its underwritten public offering of 8,560,311 shares of common stock at $64.25 per share, expecting gross proceeds of approximately $550 million.
NASDAQ
AXTI
Axt INCAXT, Inc. provides preliminary revenue and net loss guidance for the first quarter ended March 31, 2026.
NASDAQ
AXTI
Axt INCAXT, Inc. announced a net loss for Q4 and fiscal year 2025, but anticipates sequential revenue growth in Q1 2026 driven by indium phosphide for AI infrastructure.
NASDAQ
AXTI
Axt INCAXT, Inc. announced that its Board of Directors determined Leonard J. LeBlanc is now an independent director and appointed him as Chair of the Audit Committee.
NASDAQ
AXTI
Axt INCAXT, Inc. revised its fourth-quarter 2025 revenue expectations downward to $22.5-$23.5 million, citing fewer-than-expected indium phosphide export permits from China.
NASDAQ
AXTI
Axt INCAXT, Inc. announced the pricing of an underwritten public offering of common stock, raising approximately $87 million, with an option for an additional $13 million, to fund indium phosphide capacity expansion and R&D.
NASDAQ
AXTI
Axt INCAXT, Inc. announced its third quarter 2025 financial results, highlighted by a significant sequential increase in indium phosphide revenue and improved gross margins.
NASDAQ
AXTI
Axt INCAXT's subsidiary, Tongmei, has received export permits from China's Ministry of Commerce for indium phosphide, enabling resumed shipments and an expected multi-million dollar revenue increase.
NASDAQ
AXTI
Axt INCAXT, Inc. announced the appointment of Leonard J. Leblanc to its Board of Directors and Jesse Chen as Chair of the Audit Committee, effective immediately.
NASDAQ
AXTI
Axt INCAXT, Inc. announced its second quarter 2025 financial results, revealing a significant year-over-year revenue decrease and continued net losses, though gross margins showed recovery from the prior quarter's negative figures.
NASDAQ
AXTI
Axt INCAXT, Inc. filed an amended 8-K to correct the date of Nasdaq's notification regarding its non-compliance with audit committee requirements following the passing of a director.
NASDAQ
AXTI
Axt INCAXT, Inc. has disclosed non-compliance with Nasdaq's audit committee requirements following the passing of a director, but has been granted a cure period to regain compliance.
NASDAQ
AXTI
Axt INCAXT, Inc. announced the passing of Board Director Christine Russell, leading to a reduction in its Audit Committee and non-compliance with Nasdaq listing rules.
NASDAQ
AXTI
Axt INCAXT, Inc. announced preliminary second-quarter 2025 revenue of $17.5 million to $18 million, falling short of its previous guidance due to slower export permit issuance for gallium arsenide and weaker demand in China, despite strong AI-related indium phosphide demand.
NASDAQ
AXTI
Axt INCAXT, Inc.'s subsidiary, Beijing Tongmei Xtal Technology, has received initial export permits from the Chinese Ministry of Commerce, allowing it to resume shipping indium phosphide substrates to customers after previous export controls.
NASDAQ
AXTI
Axt INCAXT, Inc. stockholders approved the 2025 Equity Incentive Plan on May 15, 2025, aimed at attracting and retaining skilled personnel.
NASDAQ
AXTI
Axt INC8-K: AXT Inc. Reports Disappointing Q1 2025 Results Amidst Geopolitical Challenges and Production Issues
AXT Inc. announced a significant decline in revenue and gross margin for Q1 2025, impacted by geopolitical factors, production inefficiencies, and reduced sales.
NASDAQ
AXTI
Axt INCAXT, Inc. announces a 31% year-over-year revenue increase for fiscal year 2024, driven by growth in cloud, data center, and cell phone markets.
NASDAQ
AXTI
Axt INCAXT, Inc. saw a significant 36% year-over-year revenue increase in Q3 2024, driven by double-digit growth across all product lines, though the company still reported a net loss.
NASDAQ
AXTI
Axt INCAXT, Inc. announced a significant 50% year-over-year revenue increase for the second quarter of 2024, driven by growth in new applications and a recovering market.
NASDAQ
AXTI
Axt INCAXT Inc. stockholders approved an amendment to the 2015 Equity Incentive Plan, increasing the number of shares reserved for issuance by 3,600,000.